Kevin Spelman, PhD, MCPP, is an internationally recognized expert on the molecular biology and clinical therapeutics of botanical medicines. A past National Institutes of Health postdoctoral Fellow and Marie Curie research Fellow in the European Union, Dr. Spelman has published 27 scientific papers and six chapters and been involved in clinical work for two decades. Past research has included the molecular biology of cannabinoid receptors, brain and ovarian cancer, as well as clinical investigations, immunological studies and chemical analysis on various medicinal plants. International research has included the analysis of nutrient levels in teenage women in West Africa, working with children with neurological disorders in Central America, and researching medicinal plants active against malaria in Paris.
Dr. Spelman has been an academic pioneer in professional and competent clinical herbal medicine, co-founding the first master of science degree in clinical phytotherapy and a founding faculty member of the first bachelor degree in herbal medicine. He is an adjunct assistant professor at Massachusetts College of Pharmacy and Health Sciences, an adjunct professor of botanical medicine at National University of Natural Medicine, and a distinguished lecturer at Maryland University of Integrative Health. Dr. Spelman has advised the White House Commission on Complementary and Alternative Medicine and provided expert testimony to the Maryland House of Delegates and the Maryland Senate, as well as advised multiple companies on new product development, as well as the Jamaican government’s Scientific Research Council. Dr. Spelman is currently a natural products industry consultant specializing in pharmacology, new product development, laboratory and cGMP issues, and research initiatives.